from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2559c/-

LFCtreatmentdescriptionclass of inhibitor

-1.184

Amikacinug/mL Amikacintranslation

-1.088

Cap5-10ug/mL Capreomycintranslation

-1.391

Rox10-50 ug/mL Roxithromycintranslation

-0.752

SM2-5 ug/mL Streptomycintranslation

-2.196

Tet5-10 ug/mL Tetracyclinetranslation

1.067

Rif0.2-5ug/mL Rifampicintranscription

-1.027

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.683

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.523

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.544

CPZ10-50 ug/mL Chlorpromazinerespiration

0.790

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.108

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.586

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.261

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.210

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.467

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.115

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.426

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.382

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.205

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.973

KCN5-20 ug/mL Potassium cyaniderespiration

-0.504

NaN30.2-2 mM Sodium aziderespiration

-0.332

Nigericin50 uM Nigericinrespiration

0.688

TRC10-150 ug/mL Triclosanrespiration

0.743

TRZ10-25 ug/mL Thioridazinerespiration

-0.429

Valinomycin0.5-10 uM Valinomycinrespiration

-0.805

ZnSO42 mM ZnSO4respiration

0.021

menadione6-10 ug/mL Menadionerespiration

0.672

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.389

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.169

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.485

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.297

NRP_1Non-replicating persistence stage 1dosRassociated

-0.078

Amp0.2mg/mL AmpicillincellWall

0.143

Cephalexin20-100 ug/mL CephalexincellWall

-0.334

Cerulenin0.32-5 ug/mL CerulenincellWall

1.128

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.156

EMB10-20 ug/mL EthambutolcellWall

-0.387

Eta12-40 ug/mL EthionamidecellWall

-0.120

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.077

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.455

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.411

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.274

BZA0.12 mg/mL BenzamidearomaticAmides

0.172

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.730

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.148

H2O24 mM hydrogen peroxideDNAdamaging

1.553

Levo10 ug/mL LevofloxacinDNAdamaging

-0.314

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.480

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.753

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.702

UVUV-irradiationDNAdamaging

1.992

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.183

Antimycin12.5-50 ug/mL Antimycin A?

-0.386

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.231

PA_110-50 ug/mL Antitubercular compound PA-1?

0.133

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.796

PA8240.2-2 ug/mL PA-824?

0.491

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.418

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.483

Verapamil50 uM Verapamil?

-0.974

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.611

methoxatin10-20 ug/mL Methoxatin?